Loading this company
Loading this company
Priced within our range of £2.31 to £5.14.
£3.77GBP up +£0.02 (+0.61%)
Quoted · Prices are delayed.
Nothing we can cite explains today’s move for this company.
Our range from 3 models, on today’s numbers
£2.31–£5.14
What the price needs: revenue growth of -4.0%/yr for 5 years (our model assumes 3.1%).
Led by discounted cash flow (DCF) · Steady cash-flow business
Delayed price used by the model £3.75Prices are delayed.
Our forward range over 12 months is part of Pro. See plans
Analysts’ mean target
£417.88 across 17 analysts
The high and low of the analyst range is part of Pro. See plans
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It operates in the Drug Manufacturers - Specialty & Generic industry (Healthcare sector), headquartered in United Kingdom. The company employs roughly 24,535 people.
Prices are delayed. The feed does not say when these figures were taken.
No filings or corporate activity on file in the recent window.
No recent headlines we can cite for this company.
No insider filings for this company in the recent window.
Not investment advice. TickerWorth Score is a model output.
The score, the fair value and the reverse DCF are free on every company. Pro lets you change growth, margin and the discount rate yourself, see every valuation lens and its working, and download the model. Start a 7-day free trial — a card is required and you can cancel any time before it ends. $99 a year, or $14.99 monthly.